Skip to main content

SHELTON CAPITAL MANAGEMENT

Position in NBIX — Neurocrine Biosciences Inc

CIK 1002784 Denver, CO

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$544,215
+$118,827 QoQ
Shares Held
3,229
0.0% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#463
of 768 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SHELTON CAPITAL MANAGEMENT holds $2,556,716 across 7 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (21.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
3,229 $544,215

All Filings in NBIX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $544,215 3,229
2026-03-31 $425,388 3,229
2025-12-31 $475,981 3,356
2025-09-30 $501,437 3,572
2025-06-30 $448,964 3,572
2025-03-31 $402,141 3,636
2024-12-31 $520,201 3,811
2024-09-30 $458,345 3,978
2024-06-30 $558,114 4,054
2024-03-31 $572,368 4,150
2023-12-31 $563,274 4,275
2023-09-30 $508,050 4,516
2023-06-30 $448,962 4,761
2023-03-31 $495,674 4,897
2022-12-31 $584,897 4,897
2022-09-30 $532,749 5,016
2022-06-30 $488,959 5,016
2022-03-31 $470,250 5,016
2021-12-31 $427,212 5,016
2021-09-30 $499,499 5,208
2021-06-30 $506,842 5,208